| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| MIRA PHARMACEUTICALS, INC. | Director | Stock Options (right to buy) | 25K | Dec 9, 2024 | Direct | ||
| Telomir Pharmaceuticals, Inc. | Director | Incentive Stock Options (right to buy) | 25K | Aug 27, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| MIRA | MIRA PHARMACEUTICALS, INC. | Dec 9, 2024 | 1 | $0 | 4 | Dec 10, 2024 | Director |
| MIRA | MIRA PHARMACEUTICALS, INC. | Nov 18, 2024 | 0 | $0 | 3 | Nov 26, 2024 | Director |
| TELO | Telomir Pharmaceuticals, Inc. | Aug 27, 2024 | 1 | $0 | 4 | Aug 29, 2024 | Director |
| TELO | Telomir Pharmaceuticals, Inc. | Aug 8, 2024 | 0 | $0 | 3 | Aug 15, 2024 | Director |